Venus Remedies has joined the league of over 100 globally renowned organisations as a member of the AMR Industry Alliance (AMRIA) in continuation of its commitment to developing solutions to combat the grave public health threat posed by antimicrobial resistance (AMR).

Welcoming Venus Remedies as a new member, Melissa Mitchell, Secretariat Lead of AMR Industry Alliance, said, “As an organisation, they lead by example and make commendable efforts to counter the threat of AMR by improving the access of AMR-relevant drugs to third-world countries and encouraging appropriate antibiotic use, along with good stewardship activities."

Hailing the membership as an endorsement of the notable work done by Venus Remedies to tackle AMR, Saransh Chaudhary, CEO, Venus Medicine Research Centre (VMRC), said, “ It is an honour to collaborate with the global life sciences industry under the aegis of the AMR Industry Alliance and devise sustainable solutions to AMR. I hope this association will amplify our existing efforts against AMR at a global level by shaping relevant AMR policies and plugging the leaks in the current antibiotic research and manufacturing landscape with a focus on access and appropriate use.”